Related Experiment Video
Updated: Jan 5, 2026
Lumican Extraction from Amniotic Membrane and Determination of its Storage Temperature
Published on: October 14, 2022
Amniotic membrane for treating skin graft donor sites: A systematic review and meta-analysis
Xinglong Liang1, Li Zhou2, Jun Yan1
1Department of Dermatology, Maoming People's Hospital, Maoming, Guangdong, China.
Objective:
To evaluate the efficacy and safety of amniotic membrane (AM) for the healing of split-thickness skin graft donor sites (STSGDS).
Method:
Electronic search of PubMed, Cochrane library and EMBASE for randomized controlled trials (RCTs) or non-randomized clinical trials (NRCTs) of AM therapy in STSGDS. Review Manager5.3 was utilized to analyze and present the data.
Results:
Seven studies with 219 patients were included. Compared with other treatments, the mean difference (MD) in healing time was -3.87 days (95% CI -4.39, -3.35; P < 0.00001); Relative risk for the healing rate was 1.61 (95% CI 0.0.47-5.47; P = 0.44); There was no statistical difference in the sensation of pain (P > 0.05); The relative risk for infection rate was 0.66 (95% CI 0.29, 2.18; I2 = 0%; P = 0.65).
Conclusion:
This systematic review and meta-analysis indicate that it is effective and safe to use AM for treating STSGDS.
